Come up with a name for your new list and we'll add to it:
TwentyEight-Seven raised a round of funding on , . Investors include
Astellas Venture Management.
TwentyEight-Seven is a Cambridge, MA-based drug development firm developing small-molecule drugs that target RNA regulatory proteins, and modulate the function of specific ncRNAs that have causative r…